vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $20.2M, roughly 1.2× La Rosa Holdings Corp.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -54.6%, a 27.2% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

CBLL vs LRHC — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.2× larger
CBLL
$24.8M
$20.2M
LRHC
Higher net margin
LRHC
LRHC
27.2% more per $
LRHC
-27.4%
-54.6%
CBLL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CBLL
CBLL
LRHC
LRHC
Revenue
$24.8M
$20.2M
Net Profit
$-13.5M
$-5.5M
Gross Margin
87.3%
8.4%
Operating Margin
-58.9%
-24.7%
Net Margin
-54.6%
-27.4%
Revenue YoY
3.2%
Net Profit YoY
-125.7%
EPS (diluted)
$-0.35
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
LRHC
LRHC
Q4 25
$24.8M
Q3 25
$22.6M
$20.2M
Q2 25
$21.2M
$23.2M
Q1 25
$20.5M
$17.5M
Q4 24
$17.7M
Q3 24
$17.2M
$19.6M
Q2 24
$19.1M
Q1 24
$13.1M
Net Profit
CBLL
CBLL
LRHC
LRHC
Q4 25
$-13.5M
Q3 25
$-13.5M
$-5.5M
Q2 25
$-13.6M
$78.4M
Q1 25
$-12.8M
$-95.7M
Q4 24
$-5.1M
Q3 24
$-10.4M
$-2.5M
Q2 24
$-2.3M
Q1 24
$-4.6M
Gross Margin
CBLL
CBLL
LRHC
LRHC
Q4 25
87.3%
Q3 25
88.3%
8.4%
Q2 25
88.1%
8.0%
Q1 25
87.9%
8.8%
Q4 24
8.9%
Q3 24
87.3%
8.3%
Q2 24
8.3%
Q1 24
8.9%
Operating Margin
CBLL
CBLL
LRHC
LRHC
Q4 25
-58.9%
Q3 25
-64.8%
-24.7%
Q2 25
-70.5%
-10.6%
Q1 25
-69.3%
-26.7%
Q4 24
-17.1%
Q3 24
-57.8%
-8.9%
Q2 24
-9.7%
Q1 24
-35.0%
Net Margin
CBLL
CBLL
LRHC
LRHC
Q4 25
-54.6%
Q3 25
-59.6%
-27.4%
Q2 25
-64.4%
337.8%
Q1 25
-62.4%
-546.5%
Q4 24
-28.7%
Q3 24
-60.6%
-12.5%
Q2 24
-12.2%
Q1 24
-35.1%
EPS (diluted)
CBLL
CBLL
LRHC
LRHC
Q4 25
$-0.35
Q3 25
$-0.37
$-5.44
Q2 25
$-0.38
$15.25
Q1 25
$-0.36
$-5.86
Q4 24
$28.54
Q3 24
$-1.85
$-16.49
Q2 24
$-12.49
Q1 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$159.3M
$4.0M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$155.3M
$1.6M
Total Assets
$195.8M
$21.7M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
LRHC
LRHC
Q4 25
$159.3M
Q3 25
$168.5M
$4.0M
Q2 25
$177.4M
$5.1M
Q1 25
$182.7M
$2.9M
Q4 24
$1.4M
Q3 24
$14.1M
$1.8M
Q2 24
$1.6M
Q1 24
$1.1M
Total Debt
CBLL
CBLL
LRHC
LRHC
Q4 25
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
CBLL
CBLL
LRHC
LRHC
Q4 25
$155.3M
Q3 25
$164.1M
$1.6M
Q2 25
$172.2M
$3.4M
Q1 25
$180.9M
$-87.5M
Q4 24
$2.6M
Q3 24
$-136.0M
$5.0M
Q2 24
$4.7M
Q1 24
$5.6M
Total Assets
CBLL
CBLL
LRHC
LRHC
Q4 25
$195.8M
Q3 25
$199.5M
$21.7M
Q2 25
$207.7M
$22.9M
Q1 25
$213.5M
$21.0M
Q4 24
$19.4M
Q3 24
$47.1M
$19.7M
Q2 24
$18.7M
Q1 24
$16.3M
Debt / Equity
CBLL
CBLL
LRHC
LRHC
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
LRHC
LRHC
Operating Cash FlowLast quarter
$-10.8M
$-1.3M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
LRHC
LRHC
Q4 25
$-10.8M
Q3 25
$-11.1M
$-1.3M
Q2 25
$-7.5M
$-1.4M
Q1 25
$-11.4M
$-3.5M
Q4 24
$-1.1M
Q3 24
$-591.6K
Q2 24
$-803.1K
Q1 24
$-538.3K
Free Cash Flow
CBLL
CBLL
LRHC
LRHC
Q4 25
$-11.0M
Q3 25
$-11.5M
Q2 25
$-7.6M
Q1 25
$-11.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CBLL
CBLL
LRHC
LRHC
Q4 25
-44.2%
Q3 25
-50.8%
Q2 25
-35.9%
Q1 25
-56.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CBLL
CBLL
LRHC
LRHC
Q4 25
0.7%
Q3 25
1.6%
Q2 25
0.3%
Q1 25
0.7%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
CBLL
CBLL
LRHC
LRHC
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons